Skip to main content
. 2003 Feb;47(2):653–657. doi: 10.1128/AAC.47.2.653-657.2003

TABLE 1.

MICs and falls in viable counts after exposure to the five quinolones in concentrations attainable in human lesions (models 1 and 2)

Quinolone MIC (mg/liter) Result for model and quinolone concn (mg/liter)
Model 1 (100-day culture)
Model 2 (rifampin-tolerant persisters)
No. of colonies on 2 plates at 0.0 Δ Falla at:
No. of colonies on 2 plates at 0.0 Δ Falla at:
1.56 3.125 1.56 3.125
Ciprofloxacin 0.500 867 0.026 0.040 766 0.003 0.054
Ofloxacin 0.707 816 0.041 0.117 766 0.019 0.073
Levofloxacin 0.354 857 0.196 0.226 762 0.077 0.181
Moxifloxacin 0.177 884 0.439 0.589 760 0.222 0.466
Gatifloxacin 0.125 812 0.368 0.498 762 0.271 0.536
a

Δ Fall = (log10 CFU/milliliter after no quinolone exposure) − (log10 CFU/milliliter after exposure to 1.56 or 3.125 mg of quinolone/liter). Standard deviations of Δ fall are 0.0134 in model 1 and 0.0903 in model 2.